|
Showing 1 - 25 of
32 matches in All Departments
Despite the lack of guidance available for practitioners, extensive
polypharmacy has become the primary method of treating patients
with severe and chronic mood, anxiety, psychotic or behavioral
disorders. This ground-breaking new book provides an overview of
psychopharmacology knowledge and decision-making strategies,
integrating findings from evidence-based trials with real-world
clinical presentations. It adopts the approach and mind-set of a
clinical investigator and reveals how prescribers can practice
'bespoke psychopharmacology', tailoring care to the individualized
needs of patients. Practitioners at all levels of expertise will
enhance their ability to devise rationale-based treatments,
targeting manifestations of dysfunctional neural circuitry and
dimensions of psychopathology that cut across conventional
psychiatric diagnoses. Presented in a user-friendly, practical,
full-colour layout and incorporating summary tables, bullet points,
and illustrative case vignettes, it is an invaluable guide for all
healthcare professionals prescribing psychotropic medications,
including psychiatry specialists, primary care physicians, and
advanced practice registered nurses.
The current suicide public health crisis and advances in clinical
practice have increased the need for clear, evidence-informed
guidance on suicide prevention in healthcare. This clinical suicide
prevention handbook is an essential resource for mental health and
primary care professionals, and any practitioner aiming to ensure
their practice is up-to-date, patient-centred and consistent with
the most current standards of care. Starting with a summary of the
science and public health model of suicide, the book offers quick
tips for suicide screening, risk assessment, interventions, and
follow-up communication. It discusses medicolegal risk management,
how health systems can prevent suicide and provides highly
specialized guidance for clinicians following the loss of a patient
to suicide. Focused sections include incorporating social media
into care plans, telemedicine, issues related to culture and
race/ethnicity, and working with specific populations. It
introduces an integrated, prevention-oriented approach to suicide
prevention, incorporating realistic supports, foreseeable changes,
and strategies.
Integrating Psychotherapy and Psychopharmacology: A Handbook for
Clinicians is a practical guide for the growing number of
mental-health practitioners searching for information on treatments
that combine psychopharmacology, psychotherapy, and psychosocial
rehabilitation. Research shows that combined approaches are among
the most effective ways to treat an increasing number of
psychiatric disorders. However, though these combined treatments
are becoming the everyday practice of psychiatrists, psychologists,
and other mental-health professionals, identifying the right
treatment plan can be notoriously difficult, and clinicians are
often left scrambling to answer questions about how to design and
customize their treatment strategies. In Integrating Psychotherapy
and Psychopharmacology, readers will find these questions fully
addressed and the answers explained, and they'll come away from the
book with a toolbox full of strategies for helping their patients
improve symptoms, achieve remission, and stay well using a
combination of drug and psychological treatments.
Integrating Psychotherapy and Psychopharmacology: A Handbook for
Clinicians is a practical guide for the growing number of
mental-health practitioners searching for information on treatments
that combine psychopharmacology, psychotherapy, and psychosocial
rehabilitation. Research shows that combined approaches are among
the most effective ways to treat an increasing number of
psychiatric disorders. However, though these combined treatments
are becoming the everyday practice of psychiatrists, psychologists,
and other mental-health professionals, identifying the right
treatment plan can be notoriously difficult, and clinicians are
often left scrambling to answer questions about how to design and
customize their treatment strategies. In Integrating Psychotherapy
and Psychopharmacology, readers will find these questions fully
addressed and the answers explained, and they'll come away from the
book with a toolbox full of strategies for helping their patients
improve symptoms, achieve remission, and stay well using a
combination of drug and psychological treatments.
Drs. Stephen M. Stahl and Bret A. Moore have created an instant
classic in Anxiety Disorders: A Guide for Integrating
Psychopharmacology and Psychotherapy. Anxiety Disorders is a
comprehensive reference for the psychiatry and psychology student,
intern, or resident, early career psychiatrist or psychologist, and
the busy clinician. It distills the most important information
regarding combined treatments for anxiety and presents the material
in an easily accessible, understandable, and readable format. Each
chapter addresses a specific type of disorder: PTSD, panic,
generalized anxiety, obsessive-compulsive and other disorders, and
is authored by prominent clinicians with years of experience in
providing integrated, individualized treatments. With its thorough
exploration of psychopharmacological treatments, psychosocial
treatments, and, crucially, the integration of the two, Anxiety
Disorders is a text no 21st-century clinician or student can afford
to be without.
Drs. Stephen M. Stahl and Bret A. Moore have created an instant
classic in Anxiety Disorders: A Guide for Integrating
Psychopharmacology and Psychotherapy. Anxiety Disorders is a
comprehensive reference for the psychiatry and psychology student,
intern, or resident, early career psychiatrist or psychologist, and
the busy clinician. It distills the most important information
regarding combined treatments for anxiety and presents the material
in an easily accessible, understandable, and readable format. Each
chapter addresses a specific type of disorder: PTSD, panic,
generalized anxiety, obsessive-compulsive and other disorders, and
is authored by prominent clinicians with years of experience in
providing integrated, individualized treatments. With its thorough
exploration of psychopharmacological treatments, psychosocial
treatments, and, crucially, the integration of the two, Anxiety
Disorders is a text no 21st-century clinician or student can afford
to be without.
This spin-off from Stephen M. Stahl's new, completely revised, and
fully updated sixth edition of the Prescriber's Guide covers the
most important drugs in use today for treating patients suffering
from psychotic illness. Now established as the indispensable
formulary in psychopharmacology, easy to navigate and easy to use,
the Prescriber's Guide combines evidence-based information with
clinically informed guidance to support clinicians in making the
most effective prescribing decisions for the good of their
patients. Incorporating information on the newest indications, new
formulations, new recommendations and new safety data, this edition
continues to provide the essential practical support required by
anyone prescribing in the field of mental health.
Information about new psychotropic drugs, a summary of advances in
knowledge about identifiable risk factors for adverse effects, and
updated recommendations on viable "antidote" management
strategies-including novel pharmacotherapies for tardive dyskinesia
and newer agents for weight loss-are among the features of this
new, second edition of Managing the Side Effects of Psychotropic
Medications. Where other psychopharmacology textbooks-and, indeed,
most internships and residencies in psychiatry-lack a solid basis
in primary care medicine, this guide bridges that educational gap,
offering a thorough examination of all the effects of taking a
psychotropic drug as well practical clinical advice on how to
manage complications that arise. The book is divided into three
parts: The first deals with global issues that affect the
assessment and formulation of possible adverse effects, as well as
with pertinent concepts related to basic pharmacology, physiology,
and medical monitoring. The second part presents information
organized by individual organ systems or specific medical
circumstances. The final part focuses on summary recommendations
covering all the material presented in the book and is followed by
helpful appendixes and self-assessment questions and resources for
practitioners. This new edition includes: * Updated summaries about
what psychiatrists should know regarding drug-drug interactions,
iatrogenic cardiac arrhythmias, drug pressor effects and
orthostatic hypotension, and drug rashes; as well as updated
discussions on avoiding lithium nephrotoxicity, handling adverse
effect emergencies, and understanding new FDA classifications about
drug safety during pregnancy* An expanded discussion on the
strengths and limitations of pharmacogenetic testing to predict
adverse drug effects, as well as information about new treatments
for sexual dysfunction, sleep disturbances, cognitive complaints,
and other maladies* Revised summary tables to aid rapid assessment
and management* An expanded section on supplemental resources* An
updated and expanded self-assessment section with more key
questions Busy clinicians will find in Managing the Side Effects of
Psychotropic Medications an accessible reference that provides both
scientific and scholarly discussion of the consequences of drug
therapies they may prescribe (or avoid), the range of available
strategies to effectively manage adverse effects, and the
scientific and practical implications of their treatment decisions.
Long established as the preeminent source in its field, the eagerly
anticipated fifth edition of Dr Stahl's essential textbook of
psychopharmacology is here! With its use of icons and figures that
form Dr Stahl's unique 'visual language', the book is the single
most readable source of information on disease and drug mechanisms
for all students and mental health professionals seeking to
understand and utilize current therapeutics, and to anticipate the
future for novel medications. Every aspect of the book has been
updated, with the clarity of explanation that only Dr Stahl can
bring. The new edition includes over 500 new or refreshed figures,
an intuitive color scheme, fourteen new uses for older drugs and
eighteen brand new drugs, coverage of Parkinson's Disease
Psychosis, behavioural symptoms of dementia, and mixed features in
major depressive episodes, and expanded information on the medical
uses of cannabis and hallucinogen assisted psychotherapy.
Clinicians recognize that monitoring psychotropic levels provides
invaluable information to optimize therapy and track treatment
adherence, but they lack formal training specifically focused on
the use of plasma antipsychotic levels for these purposes. As new
technologies emerge to rapidly provide these results, the
opportunity to integrate this information into clinical care will
grow. This practical handbook clarifies confusing concepts in the
literature on use of antipsychotic levels, providing clear
explanations for the logic underlying clinically relevant concepts
such as the therapeutic threshold and the point of futility, and
how these apply to individual antipsychotics. It offers accessible
information on the expected correlation between dosages and trough
levels, and also provides a clear explanation of how to use
antipsychotic levels for monitoring oral antipsychotic adherence,
and methods to help clinicians differentiate between poor adherence
and variations in drug metabolism. An essential resource for
psychiatrists, psychiatric nurse practitioners, and mental health
professionals worldwide.
Long established as the preeminent source in its field, the eagerly
anticipated fifth edition of Dr Stahl's essential textbook of
psychopharmacology is here! With its use of icons and figures that
form Dr Stahl's unique 'visual language', the book is the single
most readable source of information on disease and drug mechanisms
for all students and mental health professionals seeking to
understand and utilize current therapeutics, and to anticipate the
future for novel medications. Every aspect of the book has been
updated, with the clarity of explanation that only Dr Stahl can
bring. The new edition includes over 500 new or refreshed figures,
an intuitive color scheme, fourteen new uses for older drugs and
eighteen brand new drugs, coverage of Parkinson's Disease
Psychosis, behavioural symptoms of dementia, and mixed features in
major depressive episodes, and expanded information on the medical
uses of cannabis and hallucinogen assisted psychotherapy.
All of the titles in the Stahl's Illustrated series are designed to
be fun. Concepts are illustrated by full-color images that will be
familiar to all readers of Stahl's Essential Psychopharmacology,
3rd Edition and The Prescriber's Guide. The texts in this
user-friendly series can be supplements to figures, images and
tables. The visual learner will find that these books make
psychopharmacology concepts easy to master, while the non-visual
learner will enjoy a shortened text version of complex
psychopharmacology concepts. Within each book, each chapter builds
on previous chapters, synthesizing information from basic biology
and diagnostics to building treatment plans and dealing with
complications and comorbidities. Novices may want to approach the
Stahl's Illustrated series by first looking through all the
graphics and gaining a feel for the visual vocabulary. Readers more
familiar with these topics should find that going back and forth
between images and text provides an interaction with which to
vividly conceptualize complex pharmacologies. And, to help guide
the reader toward more in-depth learning about particular concepts,
each book ends with a Suggested Reading section.
Stahl's Illustrated Sleep and Wake Disorders is a concise and
highly illustrated guide to the environmental, neurobiological and
genetic factors that influence sleep and wakefulness, with
evidence-based guidance for the accurate diagnosis and optimal
treatment of various sleep/wake disorders. All of the titles in the
Stahl's Illustrated series are designed to be fun. Concepts are
illustrated by full-color images that will be familiar to all
readers of Stahl's Essential Psychopharmacology and The
Prescriber's Guide. The visual learner will find that these books
make psychopharmacology concepts easy to master, while the
non-visual learner will enjoy a shortened text version of complex
psychopharmacology concepts. Within each book, each chapter builds
on previous chapters, synthesizing information from basic biology
and diagnostics to building treatment plans and dealing with
complications and comorbidities.
This volume presents up-to-date, comprehensive and high quality
reviews of the psychopharmacological evidence-base for each of the
major psychiatric disorders, written by expert
psychopharmacologists from around the world. Building on the
success of the first edition, the volume summarizes the wealth of
new developments in the field and sets them within the context of
day-to-day clinical practice. All chapters have been fully updated
and new contributions on personality disorders and substance
dependence added. Each chapter provides information about optimal
first line pharmacological interventions, maintenance
pharmacotherapy and the management of treatment-refractory
patients. The content is organized according to the DSM-V listing
of psychiatric disorders, and covers all major conditions including
schizophrenia, mood disorders, anxiety disorders, eating disorders
and Alzheimer's disorder. These issues lie at the heart of clinical
psychopharmacology, making this book invaluable to all practising
and trainee clinicians, in a mental health setting or a less
specialized environment.
Child and adolescent psychopharmacology is a rapidly growing field
with psychotropic medications used widely in the treatment of this
patient group. However, psychopharmacological treatment guidelines
used for adults cannot simply be applied for children or
adolescents, thus presenting clinicians and nurse practitioners
with assessment and prescribing challenges. Based on the
best-selling resource Stahl's Prescriber's Guide, this new book
provides a user-friendly step-by-step manual on the range of
psychotropic drugs prescribed for children and adolescents by
clinicians and nurse practitioners. Reviewed by expert child and
adolescent psychiatrists, the medications are presented in the same
design format in order to facilitate rapid access to information.
Each drug is broken down into a number of sections, each designated
by a unique color background thereby clearly distinguishing
information presented on therapeutics, safety and tolerability,
dosing and use, what to expect, special populations, and the art of
psychopharmacology, and followed by key references.
All of the titles in the Stahl's Illustrated series are designed to
be fun. Concepts are illustrated by full-color images that will be
familiar to readers of Stahl's Essential Psychopharmacology, 3rd
edition, and The Prescriber's Guide. The visual learner will find
that these books make psychopharmacology concepts easy to master,
while the non-visual learner will enjoy a shortened text version of
complex psychopharmacology concepts. Each chapter builds on
previous ones, synthesizing information from basic biology and
diagnostics to building treatment plans and dealing with
complications and comorbidities. Novices may want to begin by
looking through all the graphics and gaining a feel for the visual
vocabulary. Readers more familiar with these topics should find
that going back and forth between images and text provides an
interaction with which to vividly conceptualize complex
pharmacologies. Each book ends with a Suggested Reading section to
help guide more in-depth learning about particular concepts.
Stahl's Illustrated Violence is a concise and highly illustrated
guide to the underlying neurobiology, genetic predisposition and
management of aggressive behaviours in patients with psychiatric
disorders. All of the titles in the Stahl's Illustrated series are
designed to be fun. Concepts are illustrated by full-color images
that will be familiar to readers of Stahl's Essential
Psychopharmacology, 4th edition, and The Prescriber's Guide. The
visual learner will find that these books make psychopharmacology
concepts easy to master, while the non-visual learner will enjoy a
shortened text version of complex psychopharmacology concepts. Each
chapter builds on previous ones, synthesizing information from
basic biology and diagnostics to building treatment plans and
dealing with complications and comorbidities. Novices may want to
begin by looking through all the graphics and gaining a feel for
the visual vocabulary. Readers more familiar with these topics
should find that going back and forth between images and text
provides an interaction with which to vividly conceptualize complex
pharmacologies. Each book ends with a Suggested Reading section to
help guide more in-depth learning about particular concepts.
High-profile name in psychopharmacology Pocket-sized to ensure
portability and aid use Complex concepts are explained simply
through concise need- to-know text and high quality, color
illustrations
This spin-off from Stephen M. Stahl's new, completely revised, and
fully updated sixth edition of the Prescriber's Guide covers the
most important drugs in use today for treating depression. Now
established as the indispensable formulary in psychopharmacology,
easy to navigate and easy to use, the Prescriber's Guide combines
evidence-based information with clinically informed guidance to
support clinicians in making the most effective prescribing
decisions for the good of their patients. Incorporating information
on the newest indications, new formulations, new recommendations
and new safety data, this edition continues to provide the
essential practical support required by anyone prescribing in the
field of mental health.
Essential Pain Pharmacology: The Prescriber's Guide expertly
reviews the most important medications used to relieve pain, now
considered by many physicians as the fifth vital sign. The
catalogue of analgesics has expanded rapidly, and this text
presents the most up-to-date, comprehensive array of agents
available for prescribing. Each clear and concise drug entry covers
the range of indications, advantages and disadvantages, and tips
for appropriate dosing and avoiding adverse effects. A separate
section covers nutraceuticals, a class of drug increasingly used to
manage chronic pain, yet little discussed in medical literature.
The detailed description of each medication enables the user to
make quick and informed decisions, confident that they are best
serving the needs of their patients. Practical 'pearls' for each
entry provide a quick go-to reference for the key information to
consider before prescribing. This concise user-friendly reference
is a must-have on the shelf of every physician.
Central Nervous System disorders have an enormous impact on
individuals and on society as a whole. The development of better
treatments is crucial and is a major focus of pharmaceutical and
biotechnology companies. This book explains the complicated process
of CNS drug development in a way that is engaging for any
interested professional or student. Chapters cover each stage of
drug development, from pre-clinical research through all phases of
clinical trials, to reporting to the regulatory authorities. Other
key issues covered include strategic considerations, regulatory
constraints, dissemination of results and ethical considerations.
The user-friendly format and style enable readers to find important
information quickly and easily. Written and edited by experts from
different sectors actively engaged in CNS drug development, this is
a unique resource for drug developers, investigators, academics and
clinicians.
In medical education a lot of attention is given to what is said,
but less consideration is given to how it is said. There is
sometimes a misplaced focus on the content at the expense of the
experience for the learner. Best Practices in Medical Teaching
illustrates the general principles of effective medical
presentation. Stahl and Davis are leading experts in medical
communication and they effectively explain the practice and methods
behind their success. Applying the principles of adult learning,
they provide examples of how to design a successful lecture and
teach the reader how to influence the behaviors of their audience.
Each chapter ends with a chapter summary, progress check, and a
performance self-assessment test to ensure that the concepts are
understood. This book is an essential guide for all those involved
in the process of educating the next generation of doctors and
supporting them through their training.
The World Health Organization defines depression as a primary
contributor to the global burden of disease and predicts it will
become the second leading cause of death by 2020. The need to
develop effective therapies has never been so pressing. Current
antidepressant drugs have several limitations. This 2010 book looks
at the future of mood-disorder research, covering the
identification of new therapeutic targets, establishing new
preclinical models, new medicinal chemistry opportunities, and
fostering greater understanding of genetic influences. These
strategies are likely to help build a better picture of the disease
process, and lead to new opportunities for patient stratification
and treatment. The ultimate goal for this strand of research is to
develop more personalized and effective treatments for this chronic
and debilitating condition. This is essential reading for all those
involved in psychopharmacologic drug development, and mental health
clinicians seeking a preview of discoveries soon to influence their
practice.
All of the titles in the Stahl s Illustrated series are designed to
be fun. Concepts are illustrated by full-color images that will be
familiar to all readers of Stahl s Essential Psychopharmacology,
Third Edition and The Prescriber s Guide. The texts in this
user-friendly series can be supplements to figures, images, and
tables. The visual learner will find that these books make
psychopharmacology concepts easy to master, while the non-visual
learner will enjoy a shortened text version of complex
psychopharmacology concepts. Within each book, each chapter builds
on previous chapters, synthesizing information from basic biology
and diagnostics to building treatment plans and dealing with
complications and comorbidities. Novices may want to approach Stahl
s Illustrated series by first looking through all the graphics and
gaining a feel for the visual vocabulary. Readers more familiar
with these topics should find that going back and forth between
images and text provides an interaction with which to vividly
conceptualize complex pharmacologies. And, to help guide the reader
toward more in-depth learning about particular concepts, each book
ends with a Suggested Reading section.
|
You may like...
Barbie
Margot Robbie, Ryan Gosling, …
DVD
R194
Discovery Miles 1 940
|